Related Experiment Video
Updated: Jun 19, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state
Wasseem Rock1, Mazen Elias, Ami Lev
1Department of Internal Medicine C, Ha'emeK Medical Center, Afula, Affiliated to the Technion-Israel Institute of Technology, Faculty of Medicine, Haifa, Israel.
Abstract:
Neuroleptic malignant syndrome (NMS) is a life-threatening neurologic emergency that may be caused by neuroleptic agents of any class. The association with hyperosmolar hyperglycemic state (HHS) is rare and carries a grave prognosis. We describe the case of a 25-year-old male patient with haloperidol-induced NMS complicated by HHS that culminated in the patient's death despite all treatment efforts. Physicians caring for diabetic psychiatric patients who are treated with neuroleptic agents should be aware of this association that may be prevented by tight glycemic control.
Related Concept Videos
Hyperosmolar Hyperglycemic State
Hyperglycemia
Hypoglycemia and Glucagon
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic Ketoacidosis l: Introduction
Complications of Diabetes Mellitus

